RAD21 and ovarian cancer: Earlier investigations demonstrated that the amplification of RAD21 epigenetically restrains interferon signaling, thus promoting immune escape in ovarian cancer and having the potential to function as a molecular sign for immunotherapy regarding ovarian cancer (11).